Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-07-26
2005-07-26
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S250100, C424S251100, C424S256100, C424S279100, C530S300000, C530S350000, C530S361000, C530S412000
Reexamination Certificate
active
06921537
ABSTRACT:
Described herein is a method for removing toxic lipooligosaccharide (LOS) from outer membranes of Gram-negative cocci, such asNeisseria meningitidis. LOS-depleted outer membranes and LOS-depleted soluble outer membrane proteins can be prepared, which are able to elicit bactericidal antibodies against homologous strains of bacteria. Vaccines and other uses of the preparations are further described.
REFERENCES:
patent: 4271147 (1981-06-01), Helting et al.
patent: 4386066 (1983-05-01), O'Rourke et al.
patent: 4601903 (1986-07-01), Frasch
patent: 4707543 (1987-11-01), Zollinger et al.
patent: 5601831 (1997-02-01), Green et al.
patent: 3516017 (1986-11-01), None
patent: 0 073 169 (1983-03-01), None
patent: 0 090 660 (1983-10-01), None
patent: 0 182 401 (1986-05-01), None
patent: 0 301 992 (1989-02-01), None
patent: 0 351 604 (1990-01-01), None
patent: WO 90/06696 (1990-06-01), None
patent: WO 90/10458 (1990-09-01), None
patent: 90/13032 (1990-11-01), None
patent: WO 93/03761 (1993-03-01), None
Beuvery, E.C. et al., “Preparation and Physicochemical and Immunological Characterization of Polysaccharide-Outer Membrane Protein Complexes ofNeisseria meningitidis,” Infection and Immunity, 40(1):369-380 (1983).
Wedege, E. et al., “Restoration of Antibody Binding to Blotted Meningococcal Outer Membrane Proteins Using Various Detergents,”J. Immunol. Methods, 113:51-59 (1988).
Zlotnick, G.W. et al., “Purification and Characterization of a Peptidoglycan-Associated Lipoprotein fromHaemophilus influenzae,” J. Biol. Chem., 263(20):9790-9794 (1988).
Poolman, J.T. et al., “Comparison of Meningococcal Outer Membrane Protein Vaccines Solubilized with Detergent or C Polysaccharide,”Antonie van Leeuwenhoek J. of Microbiology, 53(6):413-419 (1987).
Kittel, J., “Isolation of Proteins from Biological Membranes by Solubilisation With Limited Amount of Detergent,” (1994)Derwent Info. Ltd. (WPI Acc No.: C86-138270) (Abstract : DE 3516017).
Helenius, A. and Simons, K., “Solubilization of Membranes by Detergents,”Biochimica et Biophysica Acta, 415:29-79 (1975).
Moriyon, I. and Berman, D.T., “Effects of Nonionic, Ionic, and Dipolar Ionic Detergents and EDTA on theBrucellaCell Envelope,”J. Bacteriology, 152(2):822-828 (1982).
Murphy, T.F. and Bartos, L.C., “Surface-Exposed and Antigenically Conserved Determinants of Outer Membrane Proteins ofBranhamella catarrhalis,” Infection and Immunity, 57(10):2938-2941 (1989).
“Other Species of Neisseria and Related Genera” InDavis Microbiology, 3rd; Gotschlich, E.C., ed.,The Niesseriae, Chapter 30, pp. 643-644.
Mandrell, R.E. and Zollinger, W.D. “Human Immune Response to Meningococcal Outer Membrane Protein Epitopes after Natural Infection or Vaccination,”Infect. Immun., 57:1590-1598 (1989).
Frasch, C.E. and Peppler, M.S., “Protection Against Group BNeisseria meningitidisDisease: Preparation of Soluble Protein and Protein-Polysaccharide Immunogens,”Infection and Immunity, 37(1):271-280 (1982).
“Centocor Stops Trials of Flagship Drug,”The Washington Post, p. D3, Jan. 19, 1993.
Spalding, B.J., “In Shocking Synergen, Sepsis Tallies Third Victim,”Bio/Technology, 11:428-429 (1993).
Peppler, M.S. and Frasch, C.E., “Protection Against Group BNeisseria meningitidisDisease, Effect of Serogroup B Polysaccharide and Polymyxin B Immunogenicity of Serotype Protein Preparations,”Infection and Immunity, 37:264-270 (1982).
Collins, M.L.P. and Salton, M.R.J., “Preparation and Crossed Immunoelectrophoretic Analysis of Cytoplasmic and Outer Membrane Fractions fromNeisseria gonorrhoeae,” Infection and Immunity, 30(1):281-288 (1980).
Mandrell, R.E. and Zollinger, W.D., “Use of a Zwitterionic Detergent for the Restoration of the Antibody-Binding Capacity of Electroblotted Meningococcal Outer Membrane Proteins,”J. Immunol. Methods, 67:1-11 (1984).
Catlin, B.W., “Branhamaceae New Family a Proposed Family to Accommodate the Genera Branhamella and Moraxella,”Int'l. J. Systematic Bact., 41(2):320-323 (1991) (Abstract only).
Saukkonen, K. et al., “Protective Efficacy of Monoclonal Antibodies to Class 1 and Class 3 Outer Membrane Proteins ofNeisseria meningitidisB:15:P1.16 in Infant Rat Infection Model: New Prospects for Vaccine Development,”Microbial Pathogenesis, 3:261-267 (1987).
Schnaitman, C.A., “Effect of Ethylenediaminetetraacetic Acid, Triton X-100, and Lysozyme on the Morphology and Chemical Composition of Isolated Cell Walls ofEscherichia coli,” J. Bacteriology, 108(1):553-563 (1971).
Frasch, C.E. and Gotschlich, E.C., “An Outer Membrane Protein ofNeisseria meningitidisGroup B Responsible for Serotype Specificity,”J. Exper. Medicine, 140:87-104 (1974).
Campagnari, A.A., et al., “Lipooligosaccharide Epitope Shared Among Gram-Negative Non-Enteric Mucosal Pathogens,”Microb Pathology, 8:353-362 (1990).
Smyth, C.J., et al., “Immunology of Outer Membrane Proteins of Gram-Negative Bacteria”,Immunology of the Bacterial Cell Envelope, Chapter 7: 177-201 (1995).
Frasch, C.E., et al., “New Developments in Meningococcal Vaccines”,Meningococcal Protein Vaccines, 633-639 (1985).
Hamilton Brook Smith & Reynolds P.C.
Swartz Rodney P
Wyeth
LandOfFree
Preparation and uses of los-depleted outer membrane proteins... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation and uses of los-depleted outer membrane proteins..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and uses of los-depleted outer membrane proteins... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3371028